ONCOLOGÍA CELULAR
![Foto de ONCOLOGÍA CELULAR](/img/grupo.png)
![Foto de Hospital Ramón y Cajal](/img/noimage_org.png)
Hospital Ramón y Cajal
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (5)
2020
-
Reply to: Comment to: Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors
European Journal of Cancer Prevention
2017
-
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681
-
Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
European Journal of Cancer, Vol. 75, pp. 73-82
-
Helicobacter pylori antibody reactivities and colorectal cancer risk in a case-control study in Spain
Frontiers in Microbiology, Vol. 8, Núm. MAY
2008
-
Cerebrotendinous xanthomatosis: Neuropathological findings
Journal of Neurology, Vol. 255, Núm. 6, pp. 839-842